Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.43 |
| ▸ | NPC1 | O15118 | 3/20 | 0.42 |
| ▸ | RAB9A | P51151 | 3/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.42 |
| ▸ | MEN1 | O00255 | 4/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | APP | P05067 | 1/20 | 0.40 |
| ▸ | GLA | P06280 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24944105 | 0.90 | ALDH1A1 (0.38) | ALDH1A1L3MBTL1KMT2AMEN1LMNA | |
| SCHEMBL26413523 | 0.88 | CYP1A2 (0.51) | ALDH1A1L3MBTL1KMT2AMAPTCYP3A4 | |
| SCHEMBL26478782 | 0.87 | KMT2A (0.40) | ALDH1A1L3MBTL1NPC1RAB9AKMT2A | |
| SCHEMBL26413601 | 0.82 | ALDH1A1 (0.51) | ALDH1A1L3MBTL1NPC1RAB9AKMT2A | |
| SCHEMBL24944882 | 0.82 | AKR1B1 (0.45) | ALDH1A1L3MBTL1KMT2AMEN1MAPT | |
| SCHEMBL26413609 | 0.81 | ALDH1A1 (0.48) | ALDH1A1L3MBTL1RAB9AKMT2AMEN1 | |
| SCHEMBL26413516 | 0.81 | MEN1 (0.43) | ALDH1A1KMT2AMEN1MAPTLMNA | |
| SCHEMBL26413712 | 0.81 | L3MBTL1 (0.39) | ALDH1A1L3MBTL1NPC1RAB9AKMT2A | |
| SCHEMBL24944664 | 0.81 | OPRM1 (0.47) | ALDH1A1KMT2AMEN1LMNA | |
| SCHEMBL24943645 | 0.81 | OPRM1 (0.41) | SMN1; SMN2CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11644753-B2 | Resist composition and patterning process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-05-09 | — | — | US | disclosed |
| US-20230131303-A1 | RESIST COMPOSITION AND PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-04-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11644753-B2 | Resist composition and patterning process | HNRNPU, NSUN2, HNRNPR | ALDH1A1 4767/4885L3MBTL1 2012/4885NPC1 4818/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.